Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

AAV5 Antikörper

AAV5 Reaktivität: Adeno-Associated Virus 5 (AAV-5) WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN926172
  • Target Alle AAV5 Produkte
    AAV5 (Adeno-Associated Virus 5 (AAV5))
    Reaktivität
    Adeno-Associated Virus 5 (AAV-5)
    Wirt
    • 4
    • 1
    Kaninchen
    Klonalität
    • 4
    • 1
    Polyklonal
    Konjugat
    • 4
    • 1
    Dieser AAV5 Antikörper ist unkonjugiert
    Applikation
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Immunogen
    AAV5 antibody was raised in rabbit using AAV-5 capsid proteins as the immunogen.
  • Applikationshinweise
    WB: 1:300-1000, IHC: 1:50-1:100, IF: 1:100-1:500, ELISA: 1:5000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    liquid form, dilute with PBS before use
    Handhabung
    Avoid repeated freeze/thaw cycles
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at 2-8 °C for short term storage. Aliquot and store at -20 °C for long term storage.
  • Long, Sandza, Holcomb, Crockett, Hayes, Arens, Fonck, Tsuruda, Schweighardt, ONeill, Zoog, Vettermann: "The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy." in: Molecular therapy. Methods & clinical development, Vol. 13, pp. 440-452, (2019) (PubMed).

    Falese, Sandza, Yates, Triffault, Gangar, Long, Tsuruda, Carter, Vettermann, Zoog, Fong: "Strategy to detect pre-existing immunity to AAV gene therapy." in: Gene therapy, Vol. 24, Issue 12, pp. 768-778, (2018) (PubMed).

  • Target
    AAV5 (Adeno-Associated Virus 5 (AAV5))
    Andere Bezeichnung
    AAV 5 (AAV5 Produkte)
    Substanzklasse
    Virus
Sie sind hier:
Kundenservice